Tavio Capital LLC - Q4 2019 holdings

$271 Million is the total value of Tavio Capital LLC's 12 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 27.3% .

 Value Shares↓ Weighting
ZBH BuyZIMMER BIOMET HLDGS INC$43,556,000
+11.5%
290,991
+2.3%
16.06%
-22.2%
HCA BuyHCA HEALTHCARE INC$33,362,000
+93.3%
225,710
+57.5%
12.30%
+34.8%
CI BuyCIGNA CORP NEW$31,763,000
+574.9%
155,326
+401.0%
11.71%
+370.8%
CNC NewCENTENE CORP DEL$30,377,000483,176
+100.0%
11.20%
LH SellLABORATORY CORP AMER HLDGS$29,893,000
-9.2%
176,703
-9.8%
11.02%
-36.7%
MOH SellMOLINA HEALTHCARE INC$25,888,000
+6.3%
190,789
-14.0%
9.54%
-25.8%
HUM BuyHUMANA INC$25,029,000
+58.2%
68,288
+10.3%
9.23%
+10.3%
MCK SellMCKESSON CORP$19,872,000
-21.6%
143,670
-22.6%
7.33%
-45.3%
BAX NewBAXTER INTL INC$10,141,000121,278
+100.0%
3.74%
PRAH BuyPRA HEALTH SCIENCES INC$8,685,000
+82.1%
78,141
+62.6%
3.20%
+27.0%
BSX  BOSTON SCIENTIFIC CORP$7,436,000
+11.1%
164,4330.0%2.74%
-22.5%
PDCO SellPATTERSON COMPANIES INC$5,269,000
-54.6%
257,289
-60.5%
1.94%
-68.3%
WMGI ExitWRIGHT MED GROUP N V$0-323,625
-100.0%
-3.53%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MOLINA HEALTHCARE INC13Q2 202029.6%
CENTENE CORP DEL11Q2 202019.1%
ANTHEM INC10Q2 201922.5%
BOSTON SCIENTIFIC CORP9Q4 201920.9%
RETROPHIN INC9Q1 20193.4%
ZIMMER BIOMET HOLDINGS INC8Q2 202020.6%
HUMANA INC8Q4 201937.8%
UNIVERSAL HLTH SVCS INC8Q1 201914.7%
HCA HEALTHCARE INC8Q1 202012.3%
MCKESSON CORP7Q2 202023.1%

View Tavio Capital LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2020-10-01
13F-HR2020-08-13
13F-HR2020-05-14
13F-HR2020-02-13
13F-HR2019-11-13
13F-HR2019-08-13
13F-HR2019-05-14
13F-HR2019-02-14
13F-HR2018-11-13
13F-HR2018-08-13

View Tavio Capital LLC's complete filings history.

Compare quarters

Export Tavio Capital LLC's holdings